State
73,598 recalls have nationwide distribution and so reach New Hampshire. 4,477 additional recalls listed New Hampshire specifically in their distribution scope.
Of the 4,477 recalls naming New Hampshire we have scored against our rubric, 603 (13%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,048 (23%) are Severe.
Which agencies issued them
These figures cover only the 4,477 recalls whose distribution notice names New Hampshire specifically. The 73,598 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Certain 2020 Audi SQ5 and Q5 vehicles and 2020-2021 Volkswagen models have improperly welded front seat frames. In a rear-end crash, the defective welds could fail and reduce occupant restraint, increasing the risk of injury.
Nature's Path is recalling Gluten-Free Organic Mesa Sunrise Cereal because it contains undeclared wheat and/or barley, posing a risk to individuals with celiac disease or gluten sensitivity.
Synthes (USA) Products LLC is recalling 191 units of DePuy Synthes Trauma LCP One-Third Tubular Plates because dimensional features may be out of tolerance, potentially reducing locking strength.
Chembio Diagnostics is recalling 7,674 kits of the DPP COVID-19 IgM/IgG System because the FDA revoked its Emergency Use Authorization due to performance issues.
Communicorp is recalling 6-inch plush Aflac Doctor Duck promotional items because the buttons on the lab coat contain lead levels exceeding federal standards.
Lannett Company, Inc. is recalling specific batches of Prednisone Tablets due to a labeling error where 2.5 mg bottles contained 10 mg tablets.
Argon Medical Devices is recalling 1,000 units of ClosureFast Micro Introducer Sheath Sets because the sterile products were manufactured under one lot with different expiration dates.
Calvin Scott & Company is recalling specific lots of Phentermine HCL capsules because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Topiramate 25mg tablets because light-sensitive drugs were repackaged in transparent pouches, violating CGMP standards.
CareFusion 303, Inc. is recalling Alaris EtCO2 Module Model 8300 units because LED display segments may appear dim, potentially affecting the visibility of infusion or patient monitoring values.
CareFusion 303, Inc. is recalling Alaris SpO2 Modules because the LED display may have dim segments, potentially affecting the visibility of infusion or patient monitoring values.
Pharmaceutical Innovations, Inc. is recalling Ultra/Phonic Focus BP Conforming Gel Pads because the device was incorrectly registered as a Class I device and requires a 510(k) submission.
Chembio Diagnostics is recalling 126 DPP Micro Reader kits because the FDA revoked their Emergency Use Authorization due to performance issues.
Calvin Scott & Co. is recalling Phentermine HCL capsules because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Hydrochlorothiazide 25mg tablets because light-sensitive products were repackaged in transparent pouches.
Chembio Diagnostics is recalling 97 DPP Micro Reader II kits because the FDA revoked their Emergency Use Authorization due to performance issues.
Cytocell Ltd. is recalling NUP98 Distal Probe Green units due to a low risk of false positive results in laboratory testing.
Calvin Scott & Co. is recalling specific lots of Thyroid 1 Grain Tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
CareFusion 303, Inc. is recalling Alaris PCA Module Model 8120 units because the LED display may show dim segments, potentially affecting the visibility of infusion or patient monitoring values.
Calvin Scott & Co. is recalling specific lots of Phentermine HCL capsules because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
CareFusion 303, Inc. is recalling Alaris Syringe Module Model 8110 units because the LED display may show dim segments, potentially affecting the visibility of infusion or patient monitoring values.
Sanofi-Aventis is recalling 7,451 vials of Elitek (rasburicase) because routine stability testing showed enzyme activity levels were out of specification.
Calvin Scott & Co. is recalling Thyroid 1 Gr tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Co. is recalling specific lots of Phendimetrazine capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phentermine HCL 37.5 mg tablets because they were repackaged in transparent pouches, violating light-sensitivity requirements.